Advantage Solutions To Sell Digital Advertising Platform Jun Group To Verve Group SE For $185M

Advantage Solutions Inc. (NASDAQ:ADV), a leading business solutions provider to consumer goods manufacturers and retailers, today announced it has entered into an agreement to sell its digital advertising platform Jun

Advantage Solutions Inc. (NASDAQ:ADV), a leading business solutions provider to consumer goods manufacturers and retailers, today announced it has entered into an agreement to sell its digital advertising platform Jun Group to Verve Group SE, a Swedish digital advertising company formerly known as Media and Games Invest SE.

 

Gross proceeds from the sale are expected to be approximately $185 million, the majority of which will be received in cash at closing. The transaction is expected to close in the third quarter, subject to regulatory and other approvals.

As part of the agreement, Verve will pay Advantage approximately $130 million in cash at close, plus two additional installments paid 12 months and 18 months post-close to complete the deal. Advantage plans to use the majority of initial proceeds to pay down debt and reinvest in the business. The company remains committed to reducing its net leverage ratio to less than 3.5 times.

 

Total
0
Shares
Related Posts
Read More

Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue And Provides Corporate Updates; Sees Q4 Revenue $69M-$71M Vs $68.27M Est.; FY23 Revenue $178M-$180M Vs $185.4M Est.; LIVMARLI Net Products Sales Of $141M-143M Expected For 2023

- $186-188 million in total revenue and $178-180 million net product sales expected for 2023, preliminary and unaudited- LIVMARLI net products sales of $141-143 million expected for 2023, representing approximately 89%

MIRM

Read More

Fed-Funded Study Finds Increase In Medical Marijuana Patient Enrollments, Chronic Pain Most Common Reason

The state-legal medical marijuana programs nationwide have seen an uptick in the number of new patients enrolled since 2020, according to newly published federal research in the journal Annals of Internal Medicine. The study, conducted by the Center for Disease Control and Prevention (CDC), the Department of Veterans Affairs (VA) and the University of Michigan showed that there were 4.1 million registered medical cannabis patients in 2022 countrywide, compared to 3.1 million in 2020. That's a 33.3% increase over two years. The researchers proposed that the increase is simultaneous with "increasing cultural acceptance of cannabis, recognition of the harm of the ‘war on drugs' (for example, mass incarceration and related consequences, such as family separation, trauma, and economic loss), and interest in the potential therapeutic properties of cannabis," reported Marijuana Moment.

TLRY